Journal List > J Korean Ophthalmol Soc > v.50(3) > 1008490

Chung and Kim: Comparison of Clinical Results Between OZil® Mode and Hyperpulse Mode in Phacoemulsification

Abstract

Purpose

To compare the intraoperative and short term postoperative outcomes of cataract surgery performed with custom pulse mode of OZil® and hyperpulse mode of conventional phacoemulsification

Methods

The patients underwent cataract surgery using the OZil® custom pulse mode phacoemulsification (Group 1, n=30) or the conventional phaco Hyperpulse mode one (Group 2, n=36) of Infiniti Vision System. Mean ultrasound time, CDE (Cumulated dissipated energy) and total BSS volume were measured during operation. Best corrected visual acuity, central corneal thickness and endothelial cell counts were checked on 1 day, 1 momth, 2 months after surgery.

Results

CDE was decreased significantly in group 1 (p<0.05). But, there were no significant differences in two groups of the mean ultrasound time and the BSS volume (p>0.05). At 2 months, the endothelial thickness was 552.94±27.95 μ m in group 1, and 568.00±31.22 μ m in group 2 and the endothelial cell counts was 2683.0±235.6 cell/mm2 and 2694.2±407.9 cell/mm2, respectatively. There were no significant differences in two groups.

Conclusions

The OZil® custom pulse mode phacoemulsification is an effective procedure in cataract surgery as much as the conventional hyperpulse mode phacoemulsification.

References

1. Vargas LG, Holzer MP, Solomon KD, et al. Endothelial cell integrity after phacoemulsification with 2 different handpieces. J Cataract Refract Surg. 2004; 30:478–82.
crossref
2. O'Brien PD, Fitzpatrick P, Kilmartin DJ, Beatty S. Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident. J Cataract Refract Surg. 2004; 30:839–43.
3. Rho CR, Kim SY, Joo CK. Clinical Result of Cataract Operation using Custom Control Software. J Korean Ophthalmol Soc. 2006; 47:735–39.
4. Liu Y, Zeng M, Liu X, et al. Torsional mode versus conventional ultrasound mode phacoemulsification: randomized comparative clinical study. J Cataract Refract Surg. 2007; 33:287–92.
5. Chylack LT Jr, Leske MC, McCarthy D. Lens Opacities Classification System II (LOCS II). Arch Ophthalmol. 1989; 107:991–7.
crossref
6. Vasavada V, Vasavada V, Raj SM, Vasavada AR. Intraoperative performance and postoperative outcomes of microcoaxial phacoemulsification: Observational study. J Cataract Refract Surg. 2007; 33:1019–24.
7. Kelman CD. Phaco-emulsification and aspiration. A new technique of cataract removal. A preliminary report. Am J Ophthalmol. 1967; 64:23–35.
8. Polack FM, Sugar A. The phacoemulsification procedure Ⅲ corneal complications. Invest Ophthalmol Vis Sci. 1977; 16:39–46.
9. Gwin RM, Warren JK, Samuelson DA, Gum GG. Effects of phacoemulsification and extracapsular lens removal on corneal thickness and endothelialcell density in the dog. Invest Ophthalmol Vis Sci. 1983; 24:227–36.
10. Strobel J, Jacobi KW. Phacoemulsification and planed ECCE: Intraoperative differences in intraocular heating. Eur J Implant Refract Surg. 1991; 3:135–8.
11. Gil SY, Kang SB, Lee SH, Chung SK. The Effect of Phaco-emulsification with Oscillation Device on the Cornea and Lens Opcatiy. J Korean Ophthalmol Soc. 2007; 47:1948–53.
12. Kim HJ, Kim JH, Lee DH. Coaxial phacoemulsification, Corneal endothelial cell damage, Microincision cataract surgery. J Korean Ophthalmol Soc. 2007; 48:19–26.
13. Hoffman RS, Fine IH, Packer M, Brown LK. Comparison of sonic and ultrasonic phacoemulsification using the Staar Sonic Wave system. J Cataract Refract Surg. 2002; 28:1581–4.
crossref
14. Mackool RJ, Brint SF. AquaLase: a new technology for cataract extraction. Curr Opin Ophthalmol. 2004; 15:40–3.
crossref
15. Vasavada AR, Raj SM, Lee YC. NeoSoniX ultrasound versus ultrasound alone for phacoemulsification; randomized clinical trial. J Cataract Refract Surg. 2004; 30:2332–5.
16. Seibel RS. Phacodynamics: Mastering the tools and techniques of phacoemulsification sergery. 4th ed.Los Angeles: SLACK;2005. p. 122–3.
17. Braga-Mele R. Thermal effect of microburst and hyperpulse settings during sleeveless bimanual phacoemulsification with advanced power modulations. J Cataract Refract Surg. 2006; 32:639–42.
crossref
18. Alio J, Rodriguez-Prats JL, Galal A, Ramzy M. Outcomes of microincision cataract versus coaxial phacoemulsification. Ophthalmology. 2005; 112:1997–2003.
19. Cameron MD, Poyer JF, Aust SD. Identification of free radicals produced during phacoemulsification. J Cataract Refract Surg. 2001; 27:463–70.
crossref

Figure 1.
Corneal thickness in 2 groups. there is no statistically significant difference between the two groups (p>0.05). Group 1=OZil® custom pulse mode phacoemulsification; Group 2=Hyperpulse mode phaco-emulsification.
jkos-50-347f1.tif
Figure 2.
Postoperative Changes in endothelial cell count (cell/mm2). Group 1=OZil® custom pulse mode phacoemulsification; Group 2=Hyperpulse mode phaco-emulsification.
jkos-50-347f2.tif
Figure 3.
Endothelial cell count change in two groups. The mean endothelial cell counts decreased 5.14% in torsional phacoemulsification and 7.07% in conventional phacoemulsification at 60 days, respectively. Group 1=OZil® custom pulse mode phacoemulsification; Group 2=Hyperpulse mode phacoemulsification.
jkos-50-347f3.tif
Table 1.
Surgical parameters used in the study with Infiniti phacoemulsification platform
  Group 1* Group 2
Incision size (mm) 3.0 mm 3.0 mm
Capsulorrhexis diameter (mm) 5.5 mm 5.5 mm
Phacoemulsification tip 30° 30°
Prechopping No No
Settings    
Amplitude/Power (Linear control) 45% (phaco) 45%
  /100% (torsional oscillation)  
Aspiration flow 45 cm3/min 45 cm3/min
Vacuum 450 mmHg 450 mmHg
Anterior chamber pressure 105 cm3-H2 O 105 cm3-H2 O
Mode Custom pulse Hyperpulse
  phaco: 100 ms on, 10 ms off (30 pps, 40% time on)
  ultrasonic oscillations: 100 ms on, 10 ms off  
I/A of cortical remnants 450 mmHg 450 mmHg
I/A of viscoelastic 150 mmHg 150 mmHg

*Group 1=OZil® custom pulse mode phacoemulsification

Group 2=Hyperpulse mode phacoemulsification.

Table 2.
Patient characteristics (N=66)
  Group 1* Group 2 p-values
Number (eye) 30 36  
Gender (M/F) 8/13 10/17  
Age 67.56±6.87 62.67±8.56 0.12
Mean Nucleus density 2.53±0.57 2.49±0.62 0.45

*Group 1=OZil® custom pulse mode phacoemulsification

Group 2=Hyperpulse mode phacoemulsification Mean± SD

Mann-Whitney U-test.

Table 3.
Comparison of mean surgical parameters between OZil® mode and hyperpulse mode
  Group 1 Group 2 p value§
Mean phaco time (sec) 16.04±7.79 16.22±16.76 0.216
CDE* (sec) 3.63±2.32 4.92±2.48 0.005
Total BSS used (cc) 54.26±8.12 56.2±4.68 0.571

*CDE=Mean Cumulative dissipated energy

Group 1=OZil® custom pulse mode phacoemulsification

Group 2=Hyperpulse mode phacoemulsification Mean± SD

§Mann-Whitney U-test.

Table 4.
Postoperative changes in corneal thickness (µm)
  Group 1* Group 2 p value
Pre-op 548.10±35.04 561.87±27.61 0.526
POD op. # 1 day 564.84±41.37 577.6±32.05 0.793
POD op. # 1 month 553.52±34.84 572.46±34.60 0.193
POD op. # 2 months 552.94±27.95 568.00±31.22 0.904

*Group 1=OZil® custom pulse mode phacoemulsification

Group 2=Hyperpulse mode phacoemulsification Mean± SD

Mann-Whitney U-test.

Table 5.
Postoperative changes in endothelial cell count (cell/mm2)
  Group 1* Group 2 p value
Pre-op 2829.3±345.74 2899.2±371.1 0.723
POD op. # 1 day 2728.3±249.0 2765.2±338.6 0.462
POD op. # 1 month 2700.4±163.2 2706.8±455.3 0.421
POD op. # 2 months 2683.8±235.6 2694.2±407.9 0.421

*Group 1=OZil® custom pulse mode phacoemulsification

Group 2=Hyperpulse mode phacoemulsification Mean± SD

Mann-Whitney U-test.

TOOLS
Similar articles